Iridex (IRIX) Long-Term Deferred Tax (2011 - 2022)
Iridex's quarterly Long-Term Deferred Tax came in at $80000.0 in Q4 2022, up 220.0% year-on-year from $25000.0 in Q4 2021, and up 220.0% quarter-over-quarter from $25000.0 in Q1 2022.
Iridex has reported Long-Term Deferred Tax for 6 years, with the latest figure at $80000.0 in Q4 2022.
- For the quarter ending Q4 2022, Long-Term Deferred Tax rose 220.0% year-over-year to $80000.0; the trailing twelve-month figure through Dec 2022 stood at $80000.0 (up 220.0% YoY), and the FY2022 full-year result was $80000.0, up 220.0% from the prior year.
- Long-Term Deferred Tax for Q4 2022 stood at $80000.0, up from $25000.0 in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $80000.0 in Q4 2022, with the low at $25000.0 in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 80,000.00 |
| Jan 1, 2022 | 25,000.00 |
| Oct 1, 2016 | 8.99 Mn |
| Jul 2, 2016 | 8.99 Mn |
| Apr 2, 2016 | 8.99 Mn |
| Jan 2, 2016 | 8.99 Mn |
| Oct 3, 2015 | 7.15 Mn |
| Jul 4, 2015 | 7.15 Mn |
| Apr 4, 2015 | 7.00 Mn |
| Jan 3, 2015 | 7.15 Mn |
| Dec 28, 2013 | 10.00 Mn |
| Dec 29, 2012 | 10.10 Mn |
| Dec 31, 2011 | 11.70 Mn |